Best Amycretin Alternatives in 2026: What You Can Actually Get Right Now

If you went looking for the best amycretin alternatives, here’s the honest truth most pages dance around: you can’t buy amycretin as an approved medication. Not at a pharmacy. Not through a telehealth clinic. Outside a legitimate clinical trial, there’s no legal way to get it. It’s still being tested — that’s what “investigational” means — and it isn’t approved in the U.S. for weight loss.¹

But the reason you searched is real. You saw the headlines — big weight-loss numbers, and a pill version — and you want something like it now. So here’s the bottom line, up front:

The closest option you can actually get today is Zepbound (tirzepatide) if you want the strongest proven results, or a once-a-day pill — Wegovy pill or Foundayo — if needles are your dealbreaker. There’s also a newer high-dose semaglutide shot, Wegovy HD, if you want that route.

Which one is right comes down to a single question: what do you actually want amycretin for? Strongest results? A pill instead of a shot? The specific way it works? The lowest cash price? Each goal has a clear, legal answer right now. We’ll show you all of them — what they cost, who they fit, and the one decision that settles it.

Find your answer fast

What are the best amycretin alternatives right now?

The best amycretin alternative depends on what you mean by “alternative.” For the most weight loss you can get today, Zepbound is the strongest FDA-approved option. For a pill, Wegovy pill and Foundayo are the two approved choices. For amycretin’s specific GLP-1 + amylin design, CagriSema is the closest — but it isn’t approved yet. No single available drug copies amycretin exactly, so we rank by the job you’re hiring the drug to do.

Here’s the short version, then the full table.

1. Zepbound (tirzepatide) — best overall option you can get now.
2. Wegovy pill (oral semaglutide) — best pill if you want the stronger oral track record.
3. Foundayo (orforglipron) — best pill if you want the easiest daily routine.
4. Wegovy HD (semaglutide 7.2 mg) — newest higher-dose semaglutide shot.
5. CagriSema — closest “amylin pathway” match, but a watchlist item (not for sale yet).
6. Retatrutide — the next big-numbers drug people compare, but it’s not amycretin-like and not approved.
7. Compounded GLP-1 programs — a cautious, later-step cash option for some people, not a true amycretin stand-in.

The Amycretin Alternative Readiness Matrix

This is the table we wish existed when we started digging. Most pages explain amycretin, or list a few drugs, or talk pricing — but nobody puts mechanism, approval status, route, evidence, real access, and the honest dealbreaker in one place. We did. Here’s where every option actually stands.

Our one honest admission: no available medicine is a perfect amycretin replacement. Zepbound is powerful and approved, but it doesn’t touch the amylin pathway. Wegovy pill and Foundayo solve the needle problem, but they’re GLP-1-only pills, not GLP-1 + amylin drugs. And compounded products aren’t FDA-approved finished medicines at all. We could pretend they’re all interchangeable. They’re not — and that’s exactly why this page sorts by your goal instead of crowning one “best.”

What is amycretin, and why can’t you get it yet?

Amycretin is an experimental Novo Nordisk drug built to hit two appetite signals at once — GLP-1 and amylin. Early trials showed up to 24.3% weight loss over 36 weeks, and it’s being developed as both a weekly shot and a daily pill. But it is not approved in the U.S. for weight loss, and it’s only available inside clinical trials.^{1, 2}

How it works, in plain English

Two hormones do the heavy lifting here:

• GLP-1 is a gut hormone that tells your brain you’re full, slows how fast your stomach empties, and helps steady blood sugar. It’s the engine behind Ozempic, Wegovy, and Zepbound.
• Amylin is a second fullness hormone. It works alongside GLP-1 to dial down appetite and food intake.

Most weight-loss drugs you can get today push the GLP-1 button (and some also push GIP, a related gut hormone). Amycretin is exciting because it’s one molecule that pushes GLP-1 and amylin together. In theory, two appetite pathways beat one. That’s the promise. “Promising,” though, is not the same as “available.”

What the trial actually showed

The buzz comes from a single early study. The main subcutaneous trial was a phase 1b/2a study — an early-stage test mostly checking safety — with 125 people at one clinic in San Antonio, Texas. Adults aged 18–55 with a BMI of 27–39.9 got a weekly amycretin shot for up to 36 weeks. Results, if people stuck with treatment: –24.3% at the 60 mg dose and –22.0% at 20 mg by week 36, versus roughly no loss on placebo.²

The honest footnotes most headlines skipped:

• This was an early, small, single-site study built mainly to test safety — not a large, final-stage trial.²
• A lot of people dropped out. The published results note a large number of withdrawals.²
• Stomach side effects were common — nausea, vomiting, and similar — and got more frequent at higher doses.²
• A separate oral (pill) study showed about 13% weight loss at 12 weeks — encouraging, but still early.²

Big early numbers, real early caveats. That’s where amycretin sits.

So can you get amycretin online?

No. Not through any normal U.S. prescription. Novo Nordisk says both the pill and shot are moving into phase 3 (the large, final testing stage).¹ The analyst firm GlobalData has estimated a U.S. approval around 2030 at the earliest — but there’s no guaranteed date, and that’s an outside projection, not a promise from the company or the FDA. Either way, it’s a multi-year wait.

One blunt warning: if a website offers to sell you “amycretin,” treat it as a red flag. There is no approved amycretin to dispense, and “research peptide” sellers are not a legal or safe path for something you put in your body. The only legitimate way to take amycretin right now is to qualify for an actual clinical trial — which we’ll show you how to check below.

How do you find a legitimate amycretin clinical trial?

The only legal way to take amycretin today is through a registered clinical trial. You can search ClinicalTrials.gov (a free U.S. government database) for “amycretin” or its development code, “NNC0487-0111,” then confirm the sponsor, your location, the eligibility rules, and whether the study is actually recruiting. Any website selling amycretin as a product to buy is not a trial — and not a safe bet.

• Search the source directly. On ClinicalTrials.gov, search amycretin or NNC0487-0111. Novo’s late-stage obesity program runs under the “AMAZE” trial names.
• Confirm it’s real. A legitimate listing names the sponsor (Novo Nordisk), specific study sites, inclusion and exclusion criteria (age, BMI, health conditions), and recruiting status.
• Know the trade-offs. In a trial you might receive a placebo, you’ll have study visits and rules, and there’s no guarantee of getting the active drug. That’s normal — it’s research, not a prescription.
• Never pay a “seller.” No legitimate trial sells you amycretin, and no pharmacy can lawfully fill “compounded amycretin,” because there’s no approved amycretin and no lawful supply of its ingredient to compound from.

If a trial isn’t a fit — and for most people it won’t be — the approved options below are where the real decision happens.

How we ranked these (our AARM framework)

We didn’t rank by hype. We scored each option on whether you can legally get it now, how strong the evidence is, how closely it matches why people want amycretin, how easy it is to actually access, how clear the price is, and how honest the downsides are. We call it the AARM framework — the Amycretin Alternative Readiness Matrix.

Our editorial readiness ratings (0–100, weighted by the factors above — these are our judgment calls, not clinical rankings):

What providers say vs. what we found

Is Zepbound the best amycretin alternative if you want the strongest option now?

For most people who want the strongest results they can actually get, Zepbound (tirzepatide) is the best amycretin alternative to ask a clinician about. It’s not an amylin drug, but tirzepatide produced 16.0%–22.5% average weight loss in its big SURMOUNT-1 trial and is already FDA-approved — so it’s prescribable today if it’s right for you.³

Why Zepbound takes the “available now” crown

• It’s FDA-approved for weight management — real oversight, real evidence.
• It works on two pathways (GLP-1 + GIP), which is part of why its results land so high.
• The numbers are strong: in the head-to-head SURMOUNT-5 trial, tirzepatide produced 20.2% weight loss versus 13.7% for semaglutide over 72 weeks.³
• You can get it through standard pharmacy and telehealth routes when a clinician signs off.

Amycretin’s top trial number (24.3%) and Zepbound’s (up to 22.5%) sit in a similar range. The difference that matters: one you can start this month, the other you can’t start for years.

What Zepbound costs without insurance

Cash prices change, but here’s the current LillyDirect self-pay structure to expect:¹³

One catch worth knowing: Lilly’s lower $449 price on the higher doses requires refilling within 45 days of your last order — miss the window and the price can jump.¹³ Verify the current terms before you commit.

Who should not default to Zepbound

We’d rather lose you to the right choice than win you to the wrong one. Look elsewhere if:

• You won’t do injections. → Jump to the pill section below.
• You specifically want the GLP-1 + amylin mechanism. → See the CagriSema watchlist.
• Your clinician finds a medical reason it’s not safe for you.
• The cash price doesn’t fit your budget and insurance won’t help. → See the cost section.

But if a weekly shot is fine and you want the strongest available option, this is your lane.

What’s the best oral amycretin alternative — Wegovy pill or Foundayo?

If the real appeal of amycretin was the pill, the best oral alternatives you can get now are Wegovy pill and Foundayo. Wegovy pill (oral semaglutide) has the longer semaglutide track record but strict dosing rules; Foundayo (orforglipron) is the only weight-loss GLP-1 pill you can take any time of day, with or without food or water.⁵

The pill trade-off most pages bury

A pill is only “easier” if its rules fit your life. Wegovy pill demands an empty-stomach routine — take it with a sip of plain water, then no food, drink, or other pills for about half an hour.⁴ If you’re someone who wakes up and immediately reaches for coffee, that rule is harder than it sounds. Foundayo has no food or water restrictions at all, which can make day-to-day sticking-with-it much simpler.⁵

The honest trade: Foundayo is the easiest to take, but in trials it produced less weight loss than the Wegovy pill, and noticeably less than Zepbound. So the pill question is really convenience vs. magnitude. Neither is wrong — it depends on what you’ll actually keep doing. See our full Wegovy pill vs. Foundayo comparison →

If “no needles” is your dealbreaker, compare the approved pills with a clinician and pick the routine you’ll stick to.

What if you want amycretin’s amylin pathway specifically?

If your real interest is amycretin’s GLP-1 + amylin mechanism — not just the weight loss — the honest answer is that no common FDA-approved U.S. option does the same thing today. The closest match in the pipeline is CagriSema, which pairs an amylin medicine (cagrilintide) with semaglutide. But Novo Nordisk has only filed it with the FDA; it isn’t approved yet.⁷

CagriSema: the amylin watchlist pick

Why it’s the closest cousin to amycretin:

• It hits the same two pathways — GLP-1 + amylin.⁷
• It’s a once-weekly shot.
• Its obesity trial (REDEFINE 1) showed 22.7% weight loss at 68 weeks if people stayed on treatment, and 20.4% across all participants regardless of adherence.⁷
• Novo has submitted it to the FDA, and it could be among the first GLP-1/amylin combination products to reach the market — but it was not approved in the U.S. or EU as of that filing.⁷

The one difference that matters for your decision: you can’t get it yet. It’s under review, not on pharmacy shelves.

Amycretin vs. CagriSema, at a glance

Why retatrutide is not an amycretin clone

You’ll see retatrutide in a lot of “next big drug” lists, and its numbers are eye-popping — about 24.2% weight loss at 48 weeks in a phase 2 trial.⁸ But it’s a different animal: it targets GLP-1, GIP, and glucagon — not amylin. It’s also still investigational and not approved. So if amylin is your reason, retatrutide isn’t your match (and again, anyone selling it as a peptide is not a legal route). If you’re weighing it anyway, see our best retatrutide GLP-1 alternatives → guide.

The takeaway: the amylin-specific options are all future drugs. If that pathway is non-negotiable for you, the realistic move is to watch CagriSema and consider a clinical trial — or start an approved option now and switch later as new drugs arrive.

Should you wait for amycretin or start an approved GLP-1 now?

For most people, waiting on an investigational drug just because the early data looks great isn’t the best move. If your weight, blood sugar, sleep apnea, heart risk, or quality of life is already a problem today, the practical step is to ask a clinician about approved options now — and keep an eye on amycretin for later. By outside estimates, amycretin likely won’t be available until around 2030.¹

Lean toward waiting / watching amycretin if:

• You only want amycretin’s exact one-molecule GLP-1 + amylin design.
• You’re genuinely fine waiting years for phase 3 results and FDA review.
• You qualify for and want to join a legitimate clinical trial.

Lean toward starting an approved option now if:

• You want something FDA-approved and available today.
• You want a pill option now (Wegovy pill or Foundayo).
• Your insurance might cover a GLP-1.
• A clinician agrees weight treatment is appropriate for you.
• You know yourself — and waiting means losing momentum.

Avoid gray-market shortcuts entirely if:

• A seller offers “amycretin” with no prescription.
• A product is sold as a “research peptide” for human use.
• There’s no licensed pharmacy, no real prescriber, and no clinical trial behind it.

The thing nobody can give you back is time. A year spent waiting for a drug that’s still years away is a year you could have spent making progress on an approved option — and switching later is always allowed.

How much do the best amycretin alternatives cost without insurance?

Amycretin has no consumer price because it isn’t approved. Among the approved alternatives, the two pills are the cheapest entry points — Foundayo’s self-pay price starts at $149/month and the Wegovy pill starts around $149/month at the starting dose — while Zepbound usually starts around $299/month and rises with dose and refill rules.^{4, 5, 13}

Real numbers, so you can plan. Prices shift, so treat these as a snapshot to verify.

A few words on reading these prices honestly. With a telehealth program like Ro, you’re paying two things: a membership and the medication. Ro lists its membership separately from medication cost.¹¹ So “from $149” is usually the medication — add the membership to see your true monthly cost. We’d rather you know that now than be surprised at checkout. One more: starting July 1, 2026, Foundayo is set to be available to eligible Medicare beneficiaries through the Medicare GLP-1 Bridge at a $50 monthly copay — worth checking if you’re on Medicare.⁵

Which provider is best for getting an amycretin alternative?

For this search, the best path is not a compounded-first pick. Ro leads for FDA-approved brand-name access plus insurance help. Sesame is the transparent cash-pay option if you want to comparison-shop. Compounded providers come last, and only after you understand that compounded drugs are not FDA-approved finished medicines.

Our take, plainly: for a page about a cutting-edge, approved-style obesity drug, the durable choice is an FDA-approved medicine from a provider that doesn’t blur the lines. Ro fits that cleanly — its weight-loss program lists Zepbound and Foundayo, and we didn’t find a compounded option on its pricing page.¹¹ Compare more options in our best GLP-1 providers → hub.

Are compounded GLP-1s amycretin alternatives?

Compounded GLP-1 programs are not true amycretin alternatives. A licensed clinician may prescribe compounded semaglutide or tirzepatide in certain legal situations, but compounded drugs are not FDA-approved finished medicines and should never be marketed as equivalent to amycretin, Wegovy, Zepbound, or any approved product.⁹

First, definitions. Compounded means a pharmacy mixes a medication itself, rather than dispensing the manufacturer’s finished, FDA-reviewed product. 503A pharmacies compound for one patient at a time with a prescription; 503B outsourcing facilities make larger batches. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which changed the rules.

Where things stand in mid-2026: this is a tightening environment, not an open one. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk-substances list, saying it found no clinical need for outsourcing facilities to compound these drugs from bulk substances. A public comment period is open through June 29, 2026.¹⁰

Say it this way (accurate): some clinicians may prescribe compounded semaglutide or tirzepatide when it’s appropriate and lawful — but compounded drugs are not FDA-approved finished medicines.

Don’t believe it framed this way: “generic Wegovy,” “generic Zepbound,” “compounded amycretin,” or “same active ingredient” used to suggest a compounded product is equivalent to an FDA-approved drug. (“Compounded amycretin” isn’t even possible — there’s no approved amycretin and no lawful supply of its ingredient.)

Who still asks about this route? Usually people with no coverage, a brand cash price out of reach, or a preference for fully online care who also understand the trade-offs. If that’s you, that’s a real conversation to have with a licensed clinician. A low-cost cash-pay telehealth program like Embody — which offers compounded options if treatment is appropriate — operates in this lane. But we’d point most readers to an FDA-approved option first, and we won’t dress a compounded product up as an amycretin stand-in.

What safety issues could change which amycretin alternative is best?

Choosing an amycretin alternative is a medical decision, not just a price or convenience one. GLP-1 and related medicines have real warnings, side effects, and reasons some people shouldn’t take them — so the right move is a clinician review, not self-diagnosis from a web page.

Flag any of these with your clinician, because they can change the answer:

• A personal or family history of medullary thyroid cancer or MEN2 (a rare genetic condition).
• A history of pancreatitis (inflammation of the pancreas).
• Gallbladder problems.
• Kidney strain, especially if vomiting leaves you dehydrated.
• Severe stomach or gut disease.
• Pregnancy, or planning a pregnancy.
• Other diabetes medications — combining them can drop blood sugar too low.
• Diabetic eye disease (retinopathy), which can shift as blood sugar improves quickly.
• For oral options, drug interactions and pill-timing matter — for example, Foundayo’s label addresses interactions and contraception timing, so ask which pill fits your other medications.
• Whether you have sleep apnea or heart disease, which may make one option a better fit than another.

These warnings come straight from the FDA-approved prescribing information for Zepbound, Wegovy, and Foundayo.¹⁴ This is exactly why we keep pointing you toward a clinician instead of a “buy now” button. The best drug on paper isn’t the best drug if it’s not safe for you.

What to ask your clinician before choosing an amycretin alternative

The sharpest question isn’t “which drug is strongest?” It’s “which option fits my health history, my route preference, my insurance, my budget, and how much uncertainty I can live with?” Walk in with a shortlist and these questions, and you’ll get a far better visit.

Best amycretin alternatives by situation

Different people mean different things by “amycretin alternative.” Find yourself below and go straight to your answer.

• You want the strongest option you can get now → Zepbound. Next step: check brand-name eligibility.
• You want a pill, full stop → Wegovy pill or Foundayo. Next step: compare the two routines and pick what you’ll keep doing.
• You want a stronger semaglutide shot → Wegovy HD (7.2 mg). Next step: ask whether it’s available to you and confirm pricing.
• You want the GLP-1 + amylin mechanism → CagriSema watchlist (and consider a clinical trial). No provider link — it’s not available yet.
• You want the lowest cash price → Compare the approved pills first; consider compounded only after the caveats and a clinician talk. Next step: compare cash prices.
• You have insurance → Ro, for the free coverage check and prior-authorization help.¹¹
• You’re needle-averse → Foundayo or Wegovy pill. Next step: check oral eligibility.
• You saw “amycretin for sale” online → Don’t treat that as a real prescription. Use the legal options in the table above, or check a real trial on ClinicalTrials.gov.

What customer reviews can and can’t tell you

Customer reviews are useful for judging a service — how smooth the signup was, how responsive support is, how clear the billing is. They cannot prove a medication is safe, effective, or right for you. Use them for the experience, not the medicine.

When you read provider reviews, weigh the operational stuff — onboarding, communication, refills, how easy it is to cancel — and treat weight-loss claims as one person’s story, not a promise of your results. Results vary a lot from person to person.

We deliberately don’t paste glowing weight-loss testimonials here. On a medical topic, that’s not proof — it’s marketing. The verified data above is the proof, and your clinician is the tiebreaker.

FAQ: Amycretin alternatives

The bottom line

Amycretin is genuinely exciting — but it’s a future drug, not a today drug. The good news is you’re not stuck waiting. If you want the strongest results you can get now, that’s Zepbound. If you want a pill, it’s Wegovy pill or Foundayo. If a stronger semaglutide shot appeals, there’s Wegovy HD. If the amylin mechanism is your reason, CagriSema is the one to watch. And if you’re not sure, you don’t have to guess.

The RX Index is independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters — clinical legitimacy, care quality, transparency, access, and cost — then help you decide where to start.